SafeGuard Surgical Receives FDA “Breakthrough” Designation, Secures Funding from Tom Pepin and NFL QB Jameis Winston
Tampa, FL, March 14, 2024 (GLOBE NEWSWIRE) — SafeGuard Surgical, a leading medical technology company focused on life-saving biodegradable solutions, announced today a major milestone in its mission to improve global healthcare. The U.S. Food and Drug Administration (FDA) has granted “Breakthrough” designation to SafeGuard Surgical’s patented biodegradable stent, LeakGuardTM. This rare honor and recognition by the FDA has only ever been bestowed upon approximately 800 medical devices.
